Where Will Pfizer Be in 5 Years?

Where Will Pfizer Be in 5 Years?

This capital isn't taking any direct routes to big pharmaceutical companies, but it's going to reverberate along Pfizer's (NYSE: PFE) bottom line eventually. Over the next five years, investors can expect a lot more new drug approvals to emerge from Pfizer's pipeline than they're used to. Here why a recent frenzy for biotech start-ups makes Pfizer a good stock to buy now and hold for the long run.